IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Pediatric Disorders
M.D. Anderson Cancer Centermonoclonal_antibodyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Pediatric Disorders cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Monomethyl Fumarate M.D. Anderson Cancer Center | Phase 1 | CC |
Thiotepa M.D. Anderson Cancer Center | Phase 1 | CC |
Cyclophosphamide M.D. Anderson Cancer Center | Phase 1 | CC |
Busulphan M.D. Anderson Cancer Center | Phase 1 | CC |
TACROLIMUS M.D. Anderson Cancer Center | Phase 1 | CC |
View all 10 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →